EXELIOM BIOSCIENCES
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 2
- Market Cap
- -
- Website
- http://www.exeliombio.com
EXL01 in the Maintenance of Steroid-induced Clinical Response/Remission in Participants With Mild to Moderate Crohn's Disease
Phase 1
Terminated
- Conditions
- Crohn Disease
- Interventions
- Drug: PlaceboOther: SoC corticosteroid - Induction PeriodOther: SoC corticosteroid - Tapering
- First Posted Date
- 2022-09-15
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- Exeliom Biosciences
- Target Recruit Count
- 8
- Registration Number
- NCT05542355
- Locations
- 🇵🇱
Zespół Poradni Specjalistycznych REUMED, Lublin, Poland
🇵🇱Centrum Medyczne "Medyk" Sp. zo.o. Sp.K, Rzeszów, Poland
🇵🇱Endoskopia Sp. z o. o., Ul. B.Chrobrego 6/8, Sopot, Poland
© Copyright 2025. All Rights Reserved by MedPath